Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
蛋白质组学分析显示 CDK6 上调是多发性骨髓瘤中来那度胺的可靶向耐药机制
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-28515-1
Yuen Lam Dora Ng #, Evelyn Ramberger #, Stephan R Bohl, Anna Dolnik, Christian Steinebach, Theresia Conrad, Sina Müller, Oliver Popp, Miriam Kull, Mohamed Haji, Michael Gütschow, Hartmut Döhner, Wolfgang Walther, Ulrich Keller, Lars Bullinger, Philipp Mertins, Jan Krönke
